Philip Kantoff
Medical Oncology · New York, NYNPI 1235107871
Payments from drug & device makers
Across 29 payments — averaging $22,169 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$625K
- Merck$16K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$17,898100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 5 | $625,000 |
| Merck | 22 | $16,233 |
| F. Hoffmann-la Roche AG | 2 | $1,665 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$11,233
- LENVIMA$5,000
- TECENTRIQ$1,110
- Non-Covered Product$555
How this compares
$642,898 in reported general payments places this provider in the 65th percentile of 498 medical oncology providers in New York.
Other medical oncology in New York
- Robert MotzerNew York$32.8M
- Alan HoNew York$32M
- Michael MorrisNew York$30.4M
- Matthew GalskyNew York$28.1M
- Wungki ParkNew York$25.5M
- Komal JhaveriNew York$22.3M
- Joshua RichterNew York$19.9M
- Jia RuanNew York$19.8M
- Andrea CercekNew York$17.8M
- Amy TierstenNew York$17.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.